Baldacci S, Besse B, Avrillon V, Mennecier B, et al. Lorlatinib for advanced anaplastic lymphoma kinase-positive non-small cell lung cancer: Results of the IFCT-1803 LORLATU cohort. Eur J Cancer 2022;166:51-59.
PMID: 35278825